PREVALENCE OF METABOLIC ASSOCIATED FATTY LIVER DISEASE WITH CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Authors

  • Yulia Sekarsari RSUP Dr. Sardjito, Yogyakarta, Indonesia
  • R. Bowo Pramono RSUP Dr. Sardjito, Yogyakarta, Indonesia
  • Vina Yanti Susanti RSUP Dr. Sardjito, Yogyakarta, Indonesia
  • M. Robikhul Ikhsan RSUP Dr. Sardjito, Yogyakarta, Indonesia
  • Hemi Sinorita RSUP Dr. Sardjito, Yogyakarta, Indonesia
  • Neneng Ratnasari RSUP Dr. Sardjito, Yogyakarta, Indonesia
  • Helmi Purba RSUP Dr. Sardjito, Yogyakarta, Indonesia

Keywords:

type 2 diabetes, metabolic, fatty liver, liver stiffness

Abstract

INTRODUCTION
Type 2 diabetes mellitus (T2DM) increases the risk of metabolic-associated fatty liver disease (MAFLD). We aimed to investigate the proportion of patients with T2DM and MAFLD and the factors associated with MAFLD among patients with T2DM in Dr. Sardjito Hospital, Yogyakarta, Indonesia.
METHODOLOGY
In a cross-sectional design study, 50 patients with T2DM were enrolled. Liver steatosis and fibrosis were assessed by Fibroscan.
RESULTS
The prevalence of MAFLD was 64%. Patients with steatosis and fibrosis had higher triglyceride levels than those with steatosis without fibrosis. The proportion of significant fibrosis (F2) and advanced fibrosis (F3) and cirrhosis (F4) were 20%,16%, and 4%, respectively. By multivariable analysis, triglyceride (OR:2,001; 95% CI: 1,570-2,054; p = 0,041) and presence of diabetes complication (OR:2,046; 95% CI: 1,865-3,728; p = 0.033) were associated with MAFLD.
CONCLUSION
Patients with T2DM have a high proportion of MAFLD and its presence is associated with serum triglyceride levels and the presence of diabetes complications.

Downloads

Download data is not yet available.

References

*

Downloads

Published

2023-11-09

How to Cite

Sekarsari, Y., Pramono, R. B., Susanti, V. Y., Ikhsan, M. R. ., Sinorita, H., Ratnasari, N. ., & Purba, H. (2023). PREVALENCE OF METABOLIC ASSOCIATED FATTY LIVER DISEASE WITH CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal of the ASEAN Federation of Endocrine Societies, 38(S3), 13. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/2965

Issue

Vol. 38 No. S3 (2023): AFES Book of Abstracts (Supplement)

Section

Oral Presentation | Diabetes

License

Copyright (c) 2023 Yulia Sekarsari, R. Bowo Pramono, Vina Yanti Susanti, M. Robikhul Ikhsan, Hemi Sinorita, Neneng Ratnasari, Helmi Purba

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).

To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.

A written agreement shall be emailed to the requester should permission be granted.